St. Jude Medical pacemakers receive FDA approval

By Angela McDaniels

Seattle, Feb. 7 - St. Jude Medical Inc. said the Food and Drug Administration has approved the company's newest platform of pacemakers, the Victory family of devices. The product family received a European CE Mark late last year.

The products will be made immediately available in the United States and Europe.

"The Victory pacemaker significantly reduced device set-up time at implant because it is pre-programmed with optimized settings that contribute to the efficiency and success of the procedure," Raymond Schaerf of Saint Joseph Medical Center in Burbank, Calif., said in a company news release.

Schaerf performed the first implant of the Victory XL DR pacemaker in the United States.

The pacemaker family includes VIP technology, an enhancement designed to promote more natural heart function and minimize ventricular pacing by allowing the patient's own heartbeat to be "in control" most of the time.

This is an important clinical consideration, the company said, because excessive ventricular pacing may contribute to heart failure in some patients.

St. Jude Medical is a medical device technology company based in St. Paul, Minn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.